State-Based Comprehensive Breast and Cervical Cancer Early Detection Programs — CFDA 93.919

Early-detection dollars on 200 cooperative-agreement records

Assistance listing 93.919 is titled COOPERATIVE AGREEMENTS FOR STATE-BASED COMPREHENSIVE BREAST AND CERVICAL CANCER EARLY DETECTION PROGRAMS in the USAspending.gov files this site indexes. The obligation total on that code is $1,035,124,205.50. An obligation is a recorded federal commitment on an award. It is not an outlay. Treating $1.04B as screening already delivered mixes two series. SpendingVault keeps the label as obligations.

200 awards sit under that dollar book. Dividing $1,035,124,205.50 by 200 produces a mean near $5.18 million per award record. That quotient is derived from the two packet totals. It is not a typical cooperative-agreement budget and not a cost per mammogram. State-based early-detection dollars often sit on a modest number of large assistance actions, which is why 200 records can carry $1.04B.

114 recipients and a 58-state geographic span

CFDA 93.919 lists 114 recipients and 58 states against 200 awards. Recipient count is not unique patients. It is how many organizational recipients the assistance extract stores for this listing. A state health department can appear on more than one award; 114 is not a census of screening clinics. The 58-state span is a coded-jurisdiction count—wider than 50—and is not a map of every mammography site.

200 awards against 114 recipients averages under two award records per recipient. Extra modifications can lift the 200 tally without moving $1,035,124,205.50 much. The 93.919 hub keeps dollars, awards, recipients, and states visible so one statistic is not inferred from another. The 58-state field is a coding fact, not a screening-coverage score.

Obligations versus screening outlays

USAspending.gov publishes obligations on assistance awards. The $1,035,124,205.50 figure for CFDA 93.919 can include commitments that will disburse later. A screening-volume report, a diagnostic-follow-up table, and a Treasury outlay series are different publications. This page does not translate the obligation total into those series.

If a number you expected is missing, the usual cause is a different reporting concept. Start from the obligation definition, then open the 93.919 program page. Do not stretch 200 awards or 114 recipients to cover every cancer-screening dollar that touches a state program.

What the 93.919 tables omit

The breast and cervical cancer early-detection hub lists award-backed obligations from USAspending.gov. It is not a patient roster, not a screening-result file, and not a wait-time dashboard. Series that never appear as assistance awards will not show up in the $1,035,124,205.50. That omission is definitional rather than a gap in the 200 award rows.

Place-of-performance on 58 states is a coding field. A statewide grantee coded to one cell can dominate geography while screenings occur in many counties. Read the program page before any state split.

How to cite CFDA 93.919

A complete citation is $1,035,124,205.50 in obligations for CFDA 93.919, covering 200 awards, 114 recipients, and 58 states, drawn from USAspending.gov assistance awards on SpendingVault. Name the series as obligations. If the question is geographic breadth rather than dollars, lead with 58 states and 114 recipients, then the $1.04B total.

Start with the Cooperative Agreements for State-Based Comprehensive Breast and Cervical Cancer Early Detection Programs page, then the all-programs index. Agency pages show awarding organizations; they do not replace this listing’s obligation total. Nothing here is medical advice.

A worked reading of the 93.919 extract

Start from the four packet facts: $1,035,124,205.50, 200 awards, 114 recipients, and 58 states under CFDA 93.919. The mean near $5.18 million is a quotient from a modest award count, not a typical screening contract. If a later USAspending.gov file adds large state actions, dollars can jump while 114 recipients barely move. If modifications proliferate, 200 can rise while the dollar book stays close to $1.04B.

Nothing in the extract splits breast from cervical screening, or detection from follow-up. Those cuts live outside this packet. Treat CFDA 93.919 as an assistance-listing tag on USAspending.gov award files. Open the program page, then the all-programs index, for a same-series ranking. Cite 200 awards and 58 states next to the dollars so the wide geography is visible.

Questions

How much is obligated under CFDA 93.919?

USAspending.gov assistance awards indexed on SpendingVault show $1,035,124,205.50 in obligations for CFDA 93.919, Cooperative Agreements for State-Based Comprehensive Breast and Cervical Cancer Early Detection Programs. That sum is an obligation total, not a Treasury outlay total and not a count of screenings. The same extract lists 200 awards, 114 recipients, and 58 states.

Why does CFDA 93.919 show 58 states?

The indexed geographic count is 58 against 200 awards and 114 recipients. That is place-of-performance coding in USAspending.gov assistance files, including jurisdictions beyond a 50-state map. The $1,035,124,205.50 obligation total still sits on those 200 award rows. State count is not a screening-coverage score.

Does the $1.04B total include money already spent on mammograms?

Not as a cash-paid sum. USAspending reports obligations—commitments to pay—rather than outlays. The $1,035,124,205.50 figure can include amounts that will disburse later. The 200-award count is a record tally, not a count of exams. Cite CFDA 93.919 with the obligation total from USAspending.gov assistance awards, not an outlay series.

How many recipients appear on CFDA 93.919?

The extract stores 114 organizational recipients for this early-detection listing. That count is not unique patients or unique clinics. Those rows still sit under the $1,035,124,205.50 obligation total, 200 awards, and 58 states. Recipient count is a file statistic on USAspending.gov assistance awards.